BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
7 results:

  • 1. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis.
    Harada H; Nie Y; Araki I; Soeno T; Chuman M; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
    PLoS One; 2021; 16(12):e0260303. PubMed ID: 34936649
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated thyroid cancer: The Influence of DNA Repair Genes Variants.
    S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature.
    Luo M; Huang Y; Li Y; Zhang Y
    BMC Gastroenterol; 2020 May; 20(1):136. PubMed ID: 32375670
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Time to Separate Persistent From Recurrent Differentiated thyroid cancer: Different Conditions With Different Outcomes.
    Sapuppo G; Tavarelli M; Belfiore A; Vigneri R; Pellegriti G
    J Clin Endocrinol Metab; 2019 Feb; 104(2):258-265. PubMed ID: 30165559
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Using Ion Torrent sequencing to study genetic mutation profiles of fatal thyroid cancers.
    Lu JY; Cheng WC; Chen KY; Lin CC; Chang CC; Kuo KT; Chen PL
    J Formos Med Assoc; 2018 Jun; 117(6):488-496. PubMed ID: 28757314
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Correlation of mlh1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
    Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
    BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.